LabCorp Prices $1B of Senior Notes | GenomeWeb

NEW YORK (GenomeWeb News) – Laboratory Corporation of America after the close of the market Monday priced $1 billion of senior notes in two tranches.

The clinical lab giant is offering $500 million of 2.2 percent senior notes due 2017 and $500 million of 3.75 percent senior notes due 2022. The notes bear interest from Aug. 23, 2012, payable in semi-annual installments on Aug. 23 and Feb. 23, beginning Feb. 23, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.